These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Combination Therapy of Serotonin Reuptake Inhibitors and Memantine for Obsessive- Compulsive Disorder: A Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials. Kishi T; Matsuda Y; Iwata N J Alzheimers Dis; 2018; 64(1):43-48. PubMed ID: 29865079 [TBL] [Abstract][Full Text] [Related]
9. Serotoninergic mechanisms in the treatment of obsessive-compulsive disorder. Goddard AW; Shekhar A; Whiteman AF; McDougle CJ Drug Discov Today; 2008 Apr; 13(7-8):325-32. PubMed ID: 18405845 [TBL] [Abstract][Full Text] [Related]
10. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder. Pigott TA; Seay SM J Clin Psychiatry; 1999 Feb; 60(2):101-6. PubMed ID: 10084636 [TBL] [Abstract][Full Text] [Related]
11. Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors and Clomipramine in Pediatric Obsessive-Compulsive Disorder. Varigonda AL; Jakubovski E; Bloch MH J Am Acad Child Adolesc Psychiatry; 2016 Oct; 55(10):851-859.e2. PubMed ID: 27663940 [TBL] [Abstract][Full Text] [Related]
12. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Mataix-Cols D; Rauch SL; Manzo PA; Jenike MA; Baer L Am J Psychiatry; 1999 Sep; 156(9):1409-16. PubMed ID: 10484953 [TBL] [Abstract][Full Text] [Related]
13. [Obsessive-compulsive disorder, frontostriatal system and the effect of the serotonergic system]. Baving L; Schmidt MH Z Kinder Jugendpsychiatr Psychother; 2000 Feb; 28(1):35-44. PubMed ID: 10746297 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of clomipramine in obsessive-compulsive disorder. Howland RH Anxiety; 1996; 2(1):56-7. PubMed ID: 9160602 [No Abstract] [Full Text] [Related]
15. Glutamatergic medication in the treatment of obsessive compulsive disorder (OCD) and autism spectrum disorder (ASD) - study protocol for a randomised controlled trial. Häge A; Banaschewski T; Buitelaar JK; Dijkhuizen RM; Franke B; Lythgoe DJ; Mechler K; Williams SC; Dittmann RW; Trials; 2016 Mar; 17(1):141. PubMed ID: 26983548 [TBL] [Abstract][Full Text] [Related]
16. Risperidone augmentation of paroxetine in a case of severe, treatment-refractory obsessive-compulsive disorder without comorbid psychopathology. Agid O; Lerer B J Clin Psychiatry; 1999 Jan; 60(1):55-6. PubMed ID: 10074882 [No Abstract] [Full Text] [Related]